Limited Competition: Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (UL1)

The summary for the Limited Competition: Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (UL1) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (UL1): The purpose of this FOA is to seek revision applications to cooperative agreements that are supporting networks or consortia of researchers who conduct or will be interested in conducting research in the following areas: The effectiveness of current human subjects protections and the development of tools and methods to examine evolving, evidence-based approaches to improve human subjects protections. The feasibility, costs, benefits, and impacts of requiring consent for research on deidentified human specimens and data using novel models of consent, e.g., notification, opt-out, opt-in, broad consent.
Federal Grant Title: Limited Competition: Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (UL1)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAS-12-167
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.350
CFDA Descriptions: National Center for Advancing Translational Sciences
Current Application Deadline: May 25, 2012
Original Application Deadline: May 25, 2012
Posted Date: Apr 20, 2012
Creation Date: Apr 20, 2012
Archive Date: Jun 25, 2012
Total Program Funding: $5,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Drug Development Collaboratory (UG3/UH3 Clinical Trial Required)
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Dis...
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Dis...
Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortenin...
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-...
A Pre-application for the NIH-Industry Pilot Program: Discovering New Therapeutic Uses for...
Limited Competition for NIH-Industry Pilot Program: Discovering New Therapeutic Uses for E...
Limited Competition for NIH-Industry Pilot Program: Discovering New Therapeutic Uses for E...
More Grants from the National Institutes of Health
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020 FederalGrants.com